SHIRE LAUNCHES MYPKFIT(TM) FOR ADVATE® [ANTIHEMOPHILIC FACTOR (RECOMBINANT)] IN THE U.S.
Mar 05, 2018 12:01 pm UTC| Business
SHIRE LAUNCHES MYPKFIT(TM) FOR ADVATE® [ANTIHEMOPHILIC FACTOR (RECOMBINANT)] IN THE U.S. First and only FDA-cleared PK dosing software now available to help healthcare professionals create personalized treatment...
Artios exercises option to in-license potential first-in-class nuclease development programme
Mar 05, 2018 12:01 pm UTC| Business
Artios Pharma Ltd ("Artios" or "the Company") Artios exercises option to in-license potential first-in-class nuclease development programme Cambridge, UK, 5 March 2018. Artios Pharma, a leading DNA Damage...
Horizon Discovery hosts Capital Markets Day today
Mar 05, 2018 12:01 pm UTC| Business
Horizon Discovery Group plc Horizon Discovery hosts Capital Markets Day today Cambridge, UK, 5 March 2018: Horizon Discovery Group plc (LSE: HZD) ("Horizon" or "the Group"), a global leader in gene editing and...
ACM Research Reports Fourth Quarter and Fiscal Year 2017 Results
Mar 05, 2018 12:01 pm UTC| Business
FREMONT, Calif., March 05, 2018 -- ACM Research, Inc. (“ACM Research” or the “Company”) (NASDAQ:ACMR), a provider of single-wafer wet cleaning equipment used by manufacturers of advanced semiconductors, today reported...
ProQR to Present at Upcoming Investor Conference
Mar 05, 2018 12:01 pm UTC| Business
LEIDEN, the Netherlands, March 05, 2018 -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to changing lives through the creation of transformative RNA medicines for the treatment of severe genetic rare...
UTStarcom to Announce Fourth Quarter and Full Year 2017 Financial Results on Friday, March 9, 2018
Mar 05, 2018 12:01 pm UTC| Business
HONG KONG, March 05, 2018 -- UTStarcom (“UTStarcom” or “the Company”) (NASDAQ:UTSI), a global telecommunications infrastructure provider, announced today that it will report its unaudited financial results for the...
Orgenesis Reports 78% Increase in Revenue for the Fourth Quarter of Fiscal 2017
Mar 05, 2018 12:01 pm UTC| Business
GERMANTOWN, Md., March 05, 2018 -- Orgenesis Inc. (OTCQB:ORGS), a leading manufacturer, service provider and developer of advanced cell therapies , today reported financial results and provided a business update for the...